(BMT) British American Tobacco - Ratings and Ratios
Exchange: XETRA • Country: United Kingdom • Currency: EUR • Type: Common Stock • ISIN: GB0002875804
BMT EPS (Earnings per Share)
BMT Revenue
BMT: Cigarettes, Heated, Vapour, Oral, Nicotine
British American Tobacco p.l.c. is a multinational tobacco company operating globally, offering a diverse portfolio of tobacco and nicotine products across various regions, including the Americas, Europe, the Asia-Pacific, the Middle East, Africa, and the United States. The companys product range encompasses vapour, heated, and modern oral nicotine products, combustible cigarettes, and traditional oral products, such as snus and moist snuff, marketed under prominent brands like Vuse, glo, Velo, Grizzly, Kodiak, Dunhill, Kent, Lucky Strike, Pall Mall, Rothmans, Newport, Natural American Spirit, and Camel. With a history dating back to 1902, the company is headquartered in London, the United Kingdom, and distributes its products to retail outlets worldwide.
From a financial perspective, British American Tobacco p.l.c. is a significant player in the tobacco industry, with a market capitalization of approximately 86.3 billion EUR. The companys stock is listed on XETRA under the ticker symbol BMT. With a history spanning over a century, the company has established a strong presence globally, leveraging its diverse brand portfolio to drive growth.
Analyzing the technical data, the stocks last price was 39.70 EUR, with short-term moving averages (SMA20 and SMA50) indicating a bullish trend, as the stock price is above both the 38.51 EUR and 37.68 EUR levels, respectively. The long-term SMA200 at 34.79 EUR further supports this trend. The Average True Range (ATR) of 0.69 EUR, equivalent to 1.74%, suggests moderate volatility. Considering the 52-week high and low of 40.00 EUR and 26.08 EUR, respectively, the stock is currently trading near its 52-week high, indicating strong market sentiment.
From a fundamental analysis perspective, the companys price-to-earnings (P/E) ratio is 24.47, while the forward P/E is significantly lower at 7.90, suggesting potential for future earnings growth. However, the return on equity (RoE) is -39.49%, indicating a challenging period for the company. Despite this, the companys diversified product portfolio and global presence may help drive future growth.
Forecasting the stocks performance based on both technical and fundamental data, we can expect a potentially bullish trend in the short term, driven by the stocks position above its short-term moving averages and the overall positive market sentiment. However, the negative RoE and the challenges facing the tobacco industry, including regulatory pressures and declining demand for combustible cigarettes, may impact the companys long-term performance. As such, a cautious approach is warranted, with a potential target price range of 42-45 EUR in the short term, contingent on the companys ability to navigate industry challenges and drive growth through its diversified product portfolio.
Additional Sources for BMT Stock
BMT Stock Overview
Market Cap in USD | 104,618m |
Sector | Consumer Defensive |
Industry | Tobacco |
GiC Sub-Industry | Tobacco |
IPO / Inception |
BMT Stock Ratings
Growth Rating | 68.7 |
Fundamental | -5.52 |
Dividend Rating | 84.6 |
Rel. Strength | 24 |
Analysts | - |
Fair Price Momentum | 42.29 EUR |
Fair Price DCF | 176.61 EUR |
BMT Dividends
Dividend Yield 12m | 8.58% |
Yield on Cost 5y | 14.23% |
Annual Growth 5y | 2.28% |
Payout Consistency | 90.7% |
Payout Ratio | 173.2% |
BMT Growth Ratios
Growth Correlation 3m | 71% |
Growth Correlation 12m | 94.1% |
Growth Correlation 5y | 72.1% |
CAGR 5y | 12.63% |
CAGR/Max DD 5y | 0.43 |
Sharpe Ratio 12m | 2.50 |
Alpha | 55.76 |
Beta | -0.030 |
Volatility | 19.90% |
Current Volume | 102.2k |
Average Volume 20d | 107k |
As of June 16, 2025, the stock is trading at EUR 42.35 with a total of 102,245 shares traded.
Over the past week, the price has changed by +1.32%, over one month by +15.11%, over three months by +13.16% and over the past year by +60.52%.
Neither. Based on ValueRay´s Fundamental Analyses, British American Tobacco is currently (June 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -5.52 and therefor a neutral outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of BMT is around 42.29 EUR . This means that BMT is currently overvalued and has a potential downside of -0.14%.
British American Tobacco has no consensus analysts rating.
According to our own proprietary Forecast Model, BMT British American Tobacco will be worth about 45.7 in June 2026. The stock is currently trading at 42.35. This means that the stock has a potential upside of +7.84%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 45.7 | 7.8% |